T-lymphokine-activated killer cell-originated protein kinase (TOPK) as a prognostic factor and a potential therapeutic target in gliomaChuntao Quan, Lin Liu|Oncotarget|2017Cited by 11
Targeting a Novel COX2/MET/TOPK Signaling Axis Overcomes gefitinib Resistance in NSCLCJuanjuan Xiao, Feng Zhu, Hui Lü et al.|SSRN Electronic Journal|2019Cited by 0